ALC (Alcon Inc.) Stock Financials & Earnings | Market Cap Arena

ALC (Alcon Inc.) Stock Financials & Earnings | Market Cap Arena

ALCAlcon Inc.

Mkt Cap$40B

Healthcare·Medical - Instruments & Supplies·🇨🇭 Switzerland·NYSE

Revenue (TTM)$10.4B

Net Income (TTM)$980M

EPS (TTM)$1.97

Free Cash Flow (TTM)$1.7B

Gross Margin54.8%

Op. Margin13.1%

Net Margin9.4%

FCF Margin16.4%

P/S Ratio (TTM)3.8x

P/E Ratio (TTM)40.6x

YoY Rev Growth+4.9%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$2.4B	$1.3B	$268M
Q2 23	$2.4B	$1.4B	$270M
Q3 23	$2.3B	$1.3B	$293M
Q4 23	$2.4B	$1.3B	$208M
Q1 24	$2.5B	$1.4B	$368M
Q2 24	$2.5B	$1.4B	$318M
Q3 24	$2.5B	$1.4B	$332M
Q4 24	$2.5B	$1.4B	$395M
Q1 25	$2.5B	$1.4B	$468M
Q2 25	$2.6B	$1.4B	$247M
Q3 25	$2.6B	$1.5B	$332M
Q4 25	$2.7B	$1.5B	$313M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q1 23	4.5x	116.7x
Q2 23	4.4x	109.9x
Q3 23	4.3x	88.4x
Q4 23	4.2x	40.8x
Q1 24	4.2x	38.0x
Q2 24	4.1x	36.1x
Q3 24	4.1x	34.3x
Q4 24	4.0x	39.1x
Q1 25	4.0x	35.5x
Q2 25	4.0x	37.1x
Q3 25	3.9x	38.0x
Q4 25	3.8x	40.6x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	$85M	-$19M
Q2 23	$324M	$103M
Q3 23	$502M	$364M
Q4 23	$479M	$109M
Q1 24	$341M	$198M
Q2 24	$530M	$410M
Q3 24	$725M	$613M
Q4 24	$463M	$313M
Q1 25	$384M	$278M
Q2 25	$505M	$403M
Q3 25	$699M	$539M
Q4 25	$658M	$489M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$104M
Q2 23	$221M
Q3 23	$138M
Q4 23	$370M
Q1 24	$143M
Q2 24	$120M
Q3 24	$111M
Q4 24	$150M
Q1 25	$106M
Q2 25	$102M
Q3 25	$160M
Q4 25	$169M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+7.4%	+7.3%
Q2 23	+9.2%	+6.7%
Q3 23	+8.8%	+5.2%
Q4 23	+8.3%	-0.3%
Q1 24	+4.5%	+0.3%
Q2 24	+3.1%	+1.2%
Q3 24	+5.4%	+4.2%
Q4 24	+6.4%	-1.7%
Q1 25	+0.6%	-4.1%
Q2 25	+4.0%	+7.9%
Q3 25	+6.5%	+7.5%
Q4 25	+8.6%	+14.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$40M	1.7%
Q2 23	$34M	1.4%
Q3 23	$35M	1.5%
Q4 23	$50M	2.1%
Q1 24	$43M	1.7%
Q2 24	$34M	1.4%
Q3 24	$0	0.0%
Q4 24	$0	0.0%
Q1 25	$39M	1.6%
Q2 25	$38M	1.5%
Q3 25	$0	0.0%
Q4 25	-$118M	-4.3%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$202M	$785M
Q2 23	$217M	$832M
Q3 23	$201M	$798M
Q4 23	$239M	$794M
Q1 24	$199M	$802M
Q2 24	$220M	$837M
Q3 24	$225M	$809M
Q4 24	$232M	$802M
Q1 25	$222M	$813M
Q2 25	$245M	$870M
Q3 25	$250M	$865M
Q4 25	$273M	$901M

Revenue by Geography

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$887M	$0	$887M
Q2 23	$660M	$0	$660M
Q3 23	$1.1B	$999K	$1.1B
Q4 23	$1.1B	$7M	$1.1B
Q1 24	$1.1B	$0	$1.1B
Q2 24	$1.4B	$2M	$1.4B
Q3 24	$1.6B	$420M	$2.0B
Q4 24	$1.7B	$154M	$1.8B
Q1 25	$1.4B	$0	$1.4B
Q2 25	$1.4B	$0	$1.4B
Q3 25	$1.5B	$0	$1.5B
Q4 25	$1.5B	$80M	$1.6B

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	496M	+0.8%
Q2 23	496M	+0.0%
Q3 23	496M	+0.1%
Q4 23	493M	-0.6%
Q1 24	497M	+0.7%
Q2 24	497M	+0.1%
Q3 24	498M	+0.1%
Q4 24	498M	-0.0%
Q1 25	498M	+0.1%
Q2 25	498M	-0.0%
Q3 25	496M	-0.4%
Q4 25	492M	-0.7%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 15	$320K	20K
FY 16	$324K	20K
FY 17	$333K	20K
FY 18	$351K	20K
FY 19	$339K	22K
FY 20	$289K	24K
FY 21	$340K	24K
FY 22	$346K	25K
FY 23	$373K	25K
FY 24	$387K	26K
FY 25	$416K	25K